Skip to main content

PPH · VanEck Pharmaceutical ETF ETF

VanEck ETF Trust

SEC fund profile
$114.21 -1.35% At close · Sep 4
Net assets $879,456,644
Holdings26
1 month
+2.74%
Year to date
+12.25%
52-week range
$85.91–$118.00
30-session avg volume
272,521

Market performance

Adjusted close · up to five years

Since Sep 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000034409
Report date
Jun 30, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings72.72%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Asset allocation

EC99.51%
STIV0.28%

Country allocation

US60.78%
GB11.84%
CH10.63%
DK5.37%
FR4.00%
IL3.06%
JP2.87%
Other1.24%

Portfolio holdings

Latest linked SEC Form NPORT-P report.

Export CSV
HoldingValueWeight
Eli Lilly & Co$177,917,44920.23%
Novartis AG$93,444,77010.63%
Merck & Co Inc$86,583,9439.85%
Novo Nordisk A/S$47,189,9795.37%
AbbVie Inc$40,231,9524.57%
Pfizer Inc$39,637,7274.51%
Bristol-Myers Squibb Co$39,303,8704.47%
GSK PLC$38,852,5514.42%
Johnson & Johnson$38,296,8984.35%
AstraZeneca PLC$38,107,1734.33%
McKesson Corp$36,254,4444.12%
Sanofi SA$35,212,8444.00%
Cencora Inc$29,513,9653.36%
Haleon PLC$27,181,5653.09%
Teva Pharmaceutical Industries Ltd$26,892,9613.06%
Takeda Pharmaceutical Co Ltd$25,255,6662.87%
Zoetis Inc$18,456,8822.10%
Viatris Inc$9,630,1881.10%
Jazz Pharmaceuticals PLC$9,502,8931.08%
Axsome Therapeutics Inc$6,752,9600.77%
Corcept Therapeutics Inc$4,431,3200.50%
Elanco Animal Health Inc$3,106,3230.35%
State Street Global Advisors$2,429,1560.28%
Organon & Co$2,014,9820.23%
Bausch Health Cos Inc$860,8620.10%
Perrigo Co PLC$528,4560.06%